Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck Tumors

NCT04297995 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

131

Enrollment

INDUSTRY

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: HLX10
DRUG: HLX07
DRUG: HLX07 placebo
DRUG: Cisplatin/Carboplatin
DRUG: 5-FU

Sponsor

Shanghai Henlius Biotech